Document is current
Any future updates will be listed below
-
Authors
Rekkas, Alexandros
Rijnbeek, Peter R.
Kent, David M.
Steyerberg, Ewout W.
van Klaveren, David
- License Information
-
More Information
Article History
Received: 17 May 2022
Accepted: 15 March 2023
First Online: 28 March 2023
Declarations
:
: Ethics approval was not required as the empirical illustration of this study was based on anonymized, publicly available data (GUSTO-I trial).
: Not applicable.
: A.R. and P.R.R. work for a research group that received/receives unconditional research grants from Yamanouchi, Pfizer-Boehringer Ingelheim, Novartis, GSK, Chiesi, Astra-Zeneca, Amgen, Janssen Research & Development. None of these relate to the content of this paper. The remaining authors have disclosed that they do not have any potential conflicts of interest.
